Given that all-oral HCV regimens are shorter in duration, better tolerated, and more effective than previous interferon-based therapies, HCV management in primary care is essential to help ensure that every patient infected with HCV is offered the opportunity to access these curative treatments.
Important NACHC Library Content Note: This technical assistance resource was developed prior to the August 2017 release of the Health Center Compliance Manual by the Health Resources and Services Administration’s (HRSA) Bureau of Primary Health Care (BPHC). The BPHC Compliance Manual, issued August 2017, indicates where PINS, PALs and other program guidance are now superseded or subsumed by the BPHC Compliance Manual.
This project was supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS).
